AirNexis Therapeutics | RoundOS

Weekly digest by email

Loading companies…

AirNexis Therapeutics | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Jan 9, 2026	Series A	$200M	Enavate Sciences — Role not disclosedFrazier Life Sciences — Role not disclosedLife Sciences at Goldman Sachs Alternatives — Role not disclosedLongitude Capital — Role not disclosedOrbiMed — Role not disclosedSR One — Role not disclosed

Investors

Enavate SciencesSeries A Frazier Life SciencesSeries A Life Sciences at Goldman Sachs AlternativesSeries A Longitude CapitalSeries A OrbiMedSeries A SR OneSeries A

Coverage

Jan 9, 2026AirNexis Therapeutics · Series A

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

TransfyrPhysical AI platform capturing real-world lab science into machine-readable data$25M · Seed

Sources

airnexis.com ↗